Search Results - "Jakobsen, Lasse H"

On estimating the time to statistical cure by Jakobsen, Lasse H, Andersson, Therese M-L, Biccler, Jorne L, Poulsen, Laurids Ø, Severinsen, Marianne T, El-Galaly, Tarec C, Bøgsted, Martin

“…The mortality risk among cancer patients measured from the time of diagnosis is often elevated in comparison to the general population. However, for some…”
Get full text

Estimating the loss of lifetime function using flexible parametric relative survival models by Jakobsen, Lasse H, Andersson, Therese M-L, Biccler, Jorne L, El-Galaly, Tarec C, Bøgsted, Martin

“…Within cancer care, dynamic evaluations of the loss in expectation of life provides useful information to patients as well as physicians. The loss of lifetime…”
Get full text

Depression and anxiety in Hodgkin lymphoma patients: A Danish nationwide cohort study of 945 patients by Øvlisen, Andreas K., Jakobsen, Lasse H., Kragholm, Kristian H., Nielsen, René E., Hutchings, Martin, Dahl‐Sørensen, Rasmus B., Frederiksen, Henrik, Stoltenberg, Danny, Bøgsted, Martin, Østgård, Lene S. G., Severinsen, Marianne T., El‐Galaly, Tarec C.

“…Cancer‐related psychological distress may lead to depression and anxiety among survivors. The vast majority of patients with Hodgkin lymphoma (HL) become…”
Get full text

Burkitt Lymphoma International Prognostic Index by Olszewski, Adam J, Jakobsen, Lasse H, Collins, Graham P, Cwynarski, Kate, Bachanova, Veronika, Blum, Kristie A, Boughan, Kirsten M, Bower, Mark, Dalla Pria, Alessia, Danilov, Alexey, David, Kevin A, Diefenbach, Catherine, Ellin, Fredrik, Epperla, Narendranath, Farooq, Umar, Feldman, Tatyana A, Gerrie, Alina S, Jagadeesh, Deepa, Kamdar, Manali, Karmali, Reem, Kassam, Shireen, Kenkre, Vaishalee P, Khan, Nadia, Kim, Seo-Hyun, Klein, Andreas K, Lossos, Izidore S, Lunning, Matthew A, Martin, Peter, Martinez-Calle, Nicolas, Montoto, Silvia, Naik, Seema, Palmisiano, Neil, Peace, David, Phillips, Elizabeth H, Phillips, Tycel J, Portell, Craig A, Reddy, Nishitha, Santarsieri, Anna, Sarraf Yazdy, Maryam, Smeland, Knut B, Smith, Scott E, Smith, Stephen D, Sundaram, Suchitra, Zayac, Adam S, Zhang, Xiao-Yin, Zhu, Catherine, Cheah, Chan Y, El-Galaly, Tarec C, Evens, Andrew M

“…Burkitt lymphoma (BL) has unique biology and clinical course but lacks a standardized prognostic model. We developed and validated a novel prognostic index…”
Get full text

High-Dose Methotrexate as CNS Prophylaxis in High-Risk Aggressive B-Cell Lymphoma by Lewis, Katharine L, Jakobsen, Lasse H, Villa, Diego, Smedby, Karin E, Savage, Kerry J, Eyre, Toby A, Cwynarski, Kate, Bishton, Mark J, Fox, Christopher P, Hawkes, Eliza A, Maurer, Matthew J, El-Galaly, Tarec C, Cheah, Chan Y

“…CNS progression or relapse is an uncommon but devastating complication of aggressive B-cell lymphoma. There is no consensus regarding the optimal approach to…”
Get full text

The impact of CHOP versus bendamustine on bone mineral density in patients with indolent lymphoma enrolled in the GALLIUM study by Pedersen, Mette Abildgaard, Gormsen, Lars C., Jakobsen, Lasse H., Eyre, Toby A., Severinsen, Marianne T., Baech, Joachim, Dann, Eldad J., Knapp, Andrea, Sahin, Denis, Vestergaard, Peter, El‐Galaly, Tarec C., Jensen, Paw

“…Summary Standard CHOP treatment includes a high cumulative dose of prednisone, and studies have shown increased fracture risk following CHOP. It is unclear…”
Get full text

Reproduction patterns among classical Hodgkin lymphoma survivors treated with BEACOPP and ABVD in Sweden, Denmark and Norway-A population-based matched cohort study by Entrop, Joshua P, Weibull, Caroline E, Smedby, Karin E, Jakobsen, Lasse H, Øvlisen, Andreas K, Molin, Daniel, Glimelius, Ingrid, Marklund, Anna, Holte, Harald, Fosså, Alexander, Smeland, Knut B, El-Galaly, Tarec C, Eloranta, Sandra

“…Childbirth rates in classical Hodgkin lymphoma (cHL) survivors have historically been reduced compared to the general population. Understanding if contemporary…”
Get full text

Bilirubin isomer distribution in jaundiced neonates during phototherapy with LED light centered at 497 nm (turquoise) vs. 459 nm (blue) by Ebbesen, Finn, Madsen, Poul H., Vandborg, Pernille K., Jakobsen, Lasse H., Trydal, Torleif, Vreman, Hendrik J.

“…Background: Phototherapy using blue light is the treatment of choice worldwide for neonatal hyperbilirubinemia. However, treatment with turquoise light may be…”
Get full text

Reproduction patterns among non-Hodgkin lymphoma survivors by subtype in Sweden, Denmark and Norway: A population-based matched cohort study by Entrop, Joshua P, Weibull, Caroline E, Smedby, Karin E, Jakobsen, Lasse H, Øvlisen, Andreas K, Glimelius, Ingrid, Marklund, Anna, Larsen, Thomas S, Holte, Harald, Fosså, Alexander, Smeland, Knut B, El-Galaly, Tarec C, Eloranta, Sandra

“…Previous studies concerning reproductive patterns among non-Hodgkin lymphoma (NHL) survivors are scarce and those available have reported conflicting results…”
Get full text

SARS‐CoV‐2 infection among patients with haematological disorders: Severity and one‐month outcome in 66 Danish patients in a nationwide cohort study by Glenthøj, Andreas, Jakobsen, Lasse H., Sengeløv, Henrik, Ahmad, Syed A., Qvist, Kristian, Rewes, Annika, Poulsen, Christian B., Overgaard, Ulrik M., Mølle, Ingolf, Severinsen, Marianne T., Strandholdt, Casper N., Maibom, Jack, Kodahl, Annette R., Ryg, Jesper, Ravn, Pernille, Johansen, Isik S., Helsø, Søren N., Jensen‐Fangel, Søren, Kisielewicz, Jacek, Wiese, Lothar, Helleberg, Marie, Kirk, Ole, Clausen, Michael R., Frederiksen, Henrik

“…Objectives Patients with haematological disorders may be particularly vulnerable to respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection; however, this is…”
Get full text

Trends in survival and cure after allogeneic haematopoietic cell transplantation for acute myeloid leukaemia from 2000 to 2020: A Danish population‐based cohort study by Gjærde, Lars K., Jakobsen, Lasse H., Juhl‐Christensen, Caroline, Olesen, Gitte, Petruskevicius, Irma, Severinsen, Marianne T., Marcher, Claus W., Theilgaard‐Mönch, Kim, Andersen, Niels S., Friis, Lone S., Kornblit, Brian, Petersen, Søren L., Schjødt, Ida, Sengeløv, Henrik

Get full text

Effect of phototherapy with turquoise vs. blue LED light of equal irradiance in jaundiced neonates by Ebbesen, Finn, Vandborg, Pernille K, Madsen, Poul H, Trydal, Torleif, Jakobsen, Lasse H, Vreman, Hendrik J

“…Background: Blue light with peak emission around 460 nm is the preferred treatment of neonatal hyperbilirubinemia. However, studies using fluorescent light…”
Get full text

Multiplex proteomics as risk predictor of infection in patients treated with hemodialysis—A prospective multicenter study by Glerup, Rie, Svensson, My, Jakobsen, Lasse H., Fellstrøm, Bengt, Jensen, Jens D., Christensen, Jeppe H.

“…Introduction Severe infection is a major problem in hemodialysis patients. Multiplex proteomics might reveal novel insights into disease mechanisms increasing…”
Get full text

Parenthood Rates and Use of Assisted Reproductive Techniques in Younger Hodgkin Lymphoma Survivors: A Danish Population-Based Study by Øvlisen, Andreas K, Jakobsen, Lasse H, Eloranta, Sandra, Kragholm, Kristian H, Hutchings, Martin, Frederiksen, Henrik, Kamper, Peter, Dahl-Sørensen, Rasmus Bo, Stoltenberg, Danny, Weibull, Caroline E, Entrop, Joshua P, Glimelius, Ingrid, Smedby, Karin E, Torp-Pedersen, Christian, Severinsen, Marianne T, El-Galaly, Tarec C

“…The majority of young adults with Hodgkin lymphoma (HL) are cured, but chemotherapy-induced infertility can have profound psychosocial consequences. Providing…”
Get full text

No survival benefit associated with routine surveillance imaging for Hodgkin lymphoma in first remission: a Danish‐Swedish population‐based observational study by Jakobsen, Lasse H., Hutchings, Martin, Nully Brown, Peter, Linderoth, Johan, Mylam, Karen J., Molin, Daniel, Johnsen, Hans E., Bøgsted, Martin, Jerkeman, Mats, El‐Galaly, Tarec C.

“…Summary The use of routine imaging for patients with classical Hodgkin lymphoma (HL) in complete remission (CR) is controversial. In a population‐based study,…”
Get full text

Relapsed/Refractory International Prognostic Index (R/R‐IPI): An international prognostic calculator for relapsed/refractory diffuse large B‐cell lymphoma by Maurer, Matthew J., Jakobsen, Lasse H., Mwangi, Raphael, Schmitz, Norbert, Farooq, Umar, Flowers, Cristopher R., Nully Brown, Peter, Thompson, Carrie A., Frederiksen, Henrik, Cunningham, David, Jørgensen, Judit, Poeschel, Viola, Nowakowski, Grzegorz, Seymour, John F., Merli, Francesco, Haioun, Corinne, Ghesquieres, Hervé, Ziepert, Marita, Tilly, Hervé, Salles, Gilles, Shi, Qian, El‐Galaly, Tarec C., Habermann, Thomas M.

“…Disease progression after frontline therapy for Diffuse large B‐cell lymphoma (DLBCL) is a clinically significant event. Patients who experience early…”
Get full text

Severity and 90-day survival of SARS-CoV-2 infection among patients with haematological disorders by Glenthøj, Andreas, Jakobsen, Lasse H, Bjørn, Mads Emil, Poulsen, Christian B, Sengeløv, Henrik, Severinsen, Marianne T, Qvist, Kristian, Overgaard, Ulrik M, Ahmad, Syed A, Rewes, Annika, Mølle, Ingolf, Strandholdt, Casper N, Kodahl, Annette R, Ryg, Jesper, Brieghel, Christian, Johansen, Isik S, Kannik, Karina, Jensen-Fangel, Søren, Wiese, Lothar, Kirk, Ole, Clausen, Michael R, Helleberg, Marie, Frederiksen, Henrik

Get more information

Risk of death, relapse or progression, and loss of life expectancy at different progression-free survival milestones in primary central nervous system lymphoma by Biccler, Jorne L., Savage, Kerry J., Brown, Peter D.N., Jørgensen, Judit, Larsen, Thomas S., Poulsen, Christian B., Stoltenberg, Danny, Sehn, Laurie H., Scott, David W., Gerrie, Alina S., Jakobsen, Lasse H., Bøgsted, Martin, El-Galaly, Tarec C., Villa, Diego

“…In this study, we analyzed the evolution of the prognosis of primary central nervous system lymphoma (PCNSL) patients as they reach selected progression-free…”
Get full text

A Randomized Placebo-Controlled Trial of Primary Prophylaxis with Weekly Alendronate Against Glucocorticoid-Induced Osteoporosis in Lymphoma Patients Treated with Steroid-Containing Chemotherapy by Jensen, Paw, Jakobsen, Lasse H., Bøgsted, Martin, Baech, Joachim, Lykkeboe, Simon, Severinsen, Marianne Tang, Vestergaard, Peter, El-Galaly, Tarec Christoffer

“…Introduction: Many lymphoma patients receive high doses of glucocorticoids as part of standard therapy, and several recent observational studies have…”
Get full text

The Impact of Trial Eligibility Criteria on Outcomes in a Nationwide Cohort of Newly Diagnosed DLBCL Patients Treated with R-CHOP by Severinsen, Freja Tang, Haunstrup, Laura Mors, Jensen, Rasmus Kuhr, Maurer, Matthew J., Khurana, Arushi, Jensen, Paw, Jørgensen, Judit M., Larsen, Thomas Stauffer, Clausen, Michael Roost, Poulsen, Christian Bjørn, Brown, Peter de Nully, El-Galaly, Tarec Christoffer, Jakobsen, Lasse H.

“…Background: Generalizability of results from clinical trials with narrow in-/exclusion criteria are a concern as significant deviations in efficacy or toxicity…”
Get full text